Zacks Upgrade Sparks New 52-Week High for Microchip Technology; Citi Targets $92

MCHPMCHP

Microchip Technology’s stock reached a new 52-week high after Zacks Research upgraded its rating from hold to strong-buy, with Citigroup raising its price target to $92 and Bank of America to $95. CEO Steve Sanghi’s sale of 18,509 shares, a 0.18% stake reduction, was disclosed in an SEC filing.

1. Earnings Outlook Strengthened by Historical Beat and Guidance

Microchip Technology enters its upcoming report with two core drivers for an anticipated earnings beat: a track record of surpassing consensus estimates and conservative forward guidance. In its latest fiscal quarter, the company delivered $0.35 in earnings per share, exceeding analyst estimates by $0.02, on revenue of $1.14 billion compared with forecasts of $1.13 billion. Although revenue was down 2.0 percent year-over-year, management has set next-quarter EPS guidance in the range of $0.34 to $0.40, signaling confidence in margin resilience. An expanding backlog in high-value industrial and automotive segments—up 5 percent sequentially—along with stable average selling prices for 8-bit and 32-bit MCUs underpin the positive outlook.

2. PIC32CM PL10 MCU Launch Expands Embedded Portfolio

On January 29, Microchip rolled out its PIC32CM PL10 family, enhancing its Arm® Cortex®-M0+ offering for low-power, cost-sensitive designs. Key features include 5 V operation, a 12-bit ADC, an integrated Peripheral Touch Controller and core-independent peripherals that offload real-time tasks. Designed for industrial control, building automation and consumer appliances, the devices support 1.8–5.5 V operation and comply with ISO 26262 functional-safety standards. Pin-to-pin compatibility with existing AVR® MCUs and broad IDE support—from MPLAB® X to Microsoft® Visual Studio Code®—aim to accelerate migration and reduce development cycles.

3. Upgrades and Ownership Trends Bolster Sentiment

Investor sentiment has strengthened following multiple analyst upgrades: Zacks elevated its rating to strong-buy and Bank of America raised its outlook to buy with a target price of 95.00, while Citigroup boosted its target to 92.00. Despite a recent CEO sale of 18,509 shares and a CFO sale of 4,292 shares, insiders still hold 1.94 percent of shares outstanding. Institutional investors control 91.51 percent of the float, with top holdings increased by AQR Capital Management (+51.3 percent) and Geneos Wealth Management (+101.8 percent). The company’s balance sheet metrics—a current ratio of 2.25, debt-to-equity of 0.80 and 1.20 quick ratio—support a quarterly dividend of 0.455 per share (annualized yield 2.3 percent).

Sources

GZD